NCT04157985
- Conditions
- Adenocarcinoma, Advanced Solid Tumors, Anal Cancer, +69 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Clinical trial condition
Carcinoma, Neuroendocrine
Explore clinical trials studying Carcinoma, Neuroendocrine. Study availability and eligibility vary by location and protocol.
230 public trials
42 recruiting studies
Carcinoma, Neuroendocrine trial results
Completed
To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
NCT01496313
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
- Locations
-
- Research Site Houston, Texas, United States
- Investigational Site Number : 1903 Olomouc, Czechia
- Research Site Olomouc, Czechia
- Investigational Site Number : 1901 Prague, Czechia
NCT00410761
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +17 more
- Locations
-
- Investigational Site Number 3 Little Rock, Arkansas, United States
- University Arkansas Site Number : 3 Little Rock, Arkansas, United States
- Investigational Site Number 8 San Francisco, California, United States
- USCF / Mt Zion Medical Center Site Number : 8 San Francisco, California, United States
NCT03126110
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +82 more
- Locations
-
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- University of Florida Gainesville, Florida, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Washington University - Siteman Cancer Center St Louis, Missouri, United States
NCT03599713
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- Stanford Cancer Institute Palo Alto, California, United States
- University of California San Francisco Comprehensive Cancer Center San Francisco, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Georgetown University Hospital Washington D.C., District of Columbia, United States
NCT04242199
- Conditions
- Adenocarcinoma, Adenoma, Advanced Solid Tumor, +67 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Henry Ford Hospital Detroit, Michigan, United States
- Upmc Cancercenter Pittsburgh, Pennsylvania, United States
- Md Anderson Cancer Center Houston, Texas, United States
NCT05534594
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +20 more
- Locations
-
- University Medical Centre Groningen Groningen, Provincie Groningen, Netherlands
Completed
Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)
NCT03783078
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
- Locations
-
- Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States
- Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States
- Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia
- Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Islet Cell, +16 more
- Locations
-
- Gustave Roussy Villejuif, Val De Marne, France
NCT02196961
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +14 more
- Locations
-
- University Hospital Essen, Dermatology Essen, North Rhine-Westphalia, Germany
- Charité Universitätsmedizin Berlin Berlin, Germany
- Elbeklinikum Buxtehude Buxtehude, Germany
- University Hospital Dresden, Dermatology Dresden, Germany